Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $8.1500 (-18.17%) ($8.0500 - $9.6700) on Thu. Mar. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.84% (three month average) | RSI | 27 | Latest Price | $8.1500(-18.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -8.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.42% in a week (0% probabilities). VIXM(-36%) VXX(-35%) TLT(-11%) UNG(-7%) IGOV(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.42% (StdDev 4.84%) | Hourly BBV | 0 () | Intraday Trend | -10.8% | | | |
|
1 - 5 Day Possible Target | $-13.05(-260.12%) | Resistance Level | $12.22 | 5 Day Moving Average | $10.53(-22.6%) | 10 Day Moving Average | $11.56(-29.5%) | 20 Day Moving Average | $12.22(-33.31%) | To recent high | -54.2% | To recent low | 0% | Market Cap | $606m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |